Cargando…
A study on the hemocompatibility of dendronized chitosan derivatives in red blood cells
Dendrimers are hyperbranched macromolecules with well-defined topological structures and multivalent functionalization sites, but they may cause cytotoxicity due to the presence of cationic charge. Recently, we have introduced alkyne-terminated poly(amidoamine) (PAMAM) dendrons of different generati...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4437608/ https://www.ncbi.nlm.nih.gov/pubmed/25999697 http://dx.doi.org/10.2147/DDDT.S77105 |
_version_ | 1782372236710117376 |
---|---|
author | Zhou, Yanfang Li, Jiemei Lu, Fang Deng, Junjie Zhang, Jiahua Fang, Peijie Peng, Xinsheng Zhou, Shu-Feng |
author_facet | Zhou, Yanfang Li, Jiemei Lu, Fang Deng, Junjie Zhang, Jiahua Fang, Peijie Peng, Xinsheng Zhou, Shu-Feng |
author_sort | Zhou, Yanfang |
collection | PubMed |
description | Dendrimers are hyperbranched macromolecules with well-defined topological structures and multivalent functionalization sites, but they may cause cytotoxicity due to the presence of cationic charge. Recently, we have introduced alkyne-terminated poly(amidoamine) (PAMAM) dendrons of different generations (G=2,3) into chitosan to obtain dendronized chitosan derivatives [Cs-g-PAMAM (G=2,3)], which exhibited a better water solubility and enhanced plasmid DNA transfection efficiency. In this study, we attempted to examine the impact of Cs-g-PAMAM (G=2,3) at different concentrations (25 μg/mL, 50 μg/mL, and 100 μg/mL) on the morphology, surface structure, and viability of rat red blood cells (RBCs). The results showed that treatment of RBCs with Cs-g-PAMAM (G=2,3) at 50 μg/mL and 100 μg/mL induced a slightly higher hemolysis than Cs, and Cs-g-PAMAM (G=3) caused a slightly higher hemolysis than Cs-g-PAMAM (G=2), but all values were <5.0%. Optical microscopic and atomic force microscopic examinations indicated that Cs-g-PAMAM (G=2,3) caused slight RBC aggregation and lysis. Treatment of RBCs with 100 μg/mL Cs-g-PAMAM (G=3) induced echinocytic transformation, and RBCs displayed characteristic irregular contour due to the folding of the periphery. Drephanocyte-like RBCs were observed when treated with 100 μg/mL Cs-g-PAMAM (G=3). Erythrocytes underwent similar shape transition upon treatment with Cs-g-PAMAM (G=2) or Cs. The roughness values (Rms) of RBCs incubated with Cs-g-PAMAM (G=2,3) were significantly larger than those for RBCs incubated with physiological saline (P<0.01), but the Rms showed no difference for Cs and Cs-g-PAMAM (G=2,3) (P>0.05). Furthermore, Cs-g-PAMAM (G=2,3) exhibited a lower cytotoxicity in human kidney 293T cells. These results indicate that Cs-g-PAMAM (G=2,3) are hemocompatible but may disturb membrane and lipid structures at higher concentrations. Further safety and biocompatibility evaluations are warranted for Cs-g-PAMAM. Our findings prove helpful for a better understanding of the advantages of combining PAMAM dendrimers and chitosan to design and develop new, safe, and effective drug delivery vehicles. |
format | Online Article Text |
id | pubmed-4437608 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | Dove Medical Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-44376082015-05-21 A study on the hemocompatibility of dendronized chitosan derivatives in red blood cells Zhou, Yanfang Li, Jiemei Lu, Fang Deng, Junjie Zhang, Jiahua Fang, Peijie Peng, Xinsheng Zhou, Shu-Feng Drug Des Devel Ther Original Research Dendrimers are hyperbranched macromolecules with well-defined topological structures and multivalent functionalization sites, but they may cause cytotoxicity due to the presence of cationic charge. Recently, we have introduced alkyne-terminated poly(amidoamine) (PAMAM) dendrons of different generations (G=2,3) into chitosan to obtain dendronized chitosan derivatives [Cs-g-PAMAM (G=2,3)], which exhibited a better water solubility and enhanced plasmid DNA transfection efficiency. In this study, we attempted to examine the impact of Cs-g-PAMAM (G=2,3) at different concentrations (25 μg/mL, 50 μg/mL, and 100 μg/mL) on the morphology, surface structure, and viability of rat red blood cells (RBCs). The results showed that treatment of RBCs with Cs-g-PAMAM (G=2,3) at 50 μg/mL and 100 μg/mL induced a slightly higher hemolysis than Cs, and Cs-g-PAMAM (G=3) caused a slightly higher hemolysis than Cs-g-PAMAM (G=2), but all values were <5.0%. Optical microscopic and atomic force microscopic examinations indicated that Cs-g-PAMAM (G=2,3) caused slight RBC aggregation and lysis. Treatment of RBCs with 100 μg/mL Cs-g-PAMAM (G=3) induced echinocytic transformation, and RBCs displayed characteristic irregular contour due to the folding of the periphery. Drephanocyte-like RBCs were observed when treated with 100 μg/mL Cs-g-PAMAM (G=3). Erythrocytes underwent similar shape transition upon treatment with Cs-g-PAMAM (G=2) or Cs. The roughness values (Rms) of RBCs incubated with Cs-g-PAMAM (G=2,3) were significantly larger than those for RBCs incubated with physiological saline (P<0.01), but the Rms showed no difference for Cs and Cs-g-PAMAM (G=2,3) (P>0.05). Furthermore, Cs-g-PAMAM (G=2,3) exhibited a lower cytotoxicity in human kidney 293T cells. These results indicate that Cs-g-PAMAM (G=2,3) are hemocompatible but may disturb membrane and lipid structures at higher concentrations. Further safety and biocompatibility evaluations are warranted for Cs-g-PAMAM. Our findings prove helpful for a better understanding of the advantages of combining PAMAM dendrimers and chitosan to design and develop new, safe, and effective drug delivery vehicles. Dove Medical Press 2015-05-14 /pmc/articles/PMC4437608/ /pubmed/25999697 http://dx.doi.org/10.2147/DDDT.S77105 Text en © 2015 Zhou et al. This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution – Non Commercial (unported, v3.0) License The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. |
spellingShingle | Original Research Zhou, Yanfang Li, Jiemei Lu, Fang Deng, Junjie Zhang, Jiahua Fang, Peijie Peng, Xinsheng Zhou, Shu-Feng A study on the hemocompatibility of dendronized chitosan derivatives in red blood cells |
title | A study on the hemocompatibility of dendronized chitosan derivatives in red blood cells |
title_full | A study on the hemocompatibility of dendronized chitosan derivatives in red blood cells |
title_fullStr | A study on the hemocompatibility of dendronized chitosan derivatives in red blood cells |
title_full_unstemmed | A study on the hemocompatibility of dendronized chitosan derivatives in red blood cells |
title_short | A study on the hemocompatibility of dendronized chitosan derivatives in red blood cells |
title_sort | study on the hemocompatibility of dendronized chitosan derivatives in red blood cells |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4437608/ https://www.ncbi.nlm.nih.gov/pubmed/25999697 http://dx.doi.org/10.2147/DDDT.S77105 |
work_keys_str_mv | AT zhouyanfang astudyonthehemocompatibilityofdendronizedchitosanderivativesinredbloodcells AT lijiemei astudyonthehemocompatibilityofdendronizedchitosanderivativesinredbloodcells AT lufang astudyonthehemocompatibilityofdendronizedchitosanderivativesinredbloodcells AT dengjunjie astudyonthehemocompatibilityofdendronizedchitosanderivativesinredbloodcells AT zhangjiahua astudyonthehemocompatibilityofdendronizedchitosanderivativesinredbloodcells AT fangpeijie astudyonthehemocompatibilityofdendronizedchitosanderivativesinredbloodcells AT pengxinsheng astudyonthehemocompatibilityofdendronizedchitosanderivativesinredbloodcells AT zhoushufeng astudyonthehemocompatibilityofdendronizedchitosanderivativesinredbloodcells AT zhouyanfang studyonthehemocompatibilityofdendronizedchitosanderivativesinredbloodcells AT lijiemei studyonthehemocompatibilityofdendronizedchitosanderivativesinredbloodcells AT lufang studyonthehemocompatibilityofdendronizedchitosanderivativesinredbloodcells AT dengjunjie studyonthehemocompatibilityofdendronizedchitosanderivativesinredbloodcells AT zhangjiahua studyonthehemocompatibilityofdendronizedchitosanderivativesinredbloodcells AT fangpeijie studyonthehemocompatibilityofdendronizedchitosanderivativesinredbloodcells AT pengxinsheng studyonthehemocompatibilityofdendronizedchitosanderivativesinredbloodcells AT zhoushufeng studyonthehemocompatibilityofdendronizedchitosanderivativesinredbloodcells |